Another way to learn is a UNESCO initiative that supports Non-Formal Education projects working around the world in Africa, South Asia, the Caribbean and Latin America.
Sex politics Reports from the front lines is the outcome of a project launched by Sexuality Policy Watch (SWP) in 2004: a transnational, cross cultural research initiative to capture some dynamic of sexual politics in our time.
This aide memoire presents the results of a country case study of Thailand which took place in the context of a four-country exercise commissioned by the UNAIDS Inter-Agency Task Team (IATT) on Education.
The United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific (UN RTF) commissioned the Centre for Harm Reduction (CHR), Macfarlane Burnet Institute for Medical Research and Public Health, Australia to undertake a baseline assessment of current policies, progr
The study described here explores, for three regions with generalized HIV and AIDS epidemics, the impact of the epidemic on teacher supply now and up to 2015, the target date for the achievement of education for all.
This paper is a collection, both previously published and new, describing efforts in the Asia/Pacific region to target young women with HIV prevention health messages.
This paper examines the impact of HIV and AIDS on education in the Greater Mekong Subregion using thje Ed-SIDA model, looking at the demand for and the supply of education.
Around the world youth often do not have access to basic sexual and reproductive health (SRH) information, skills in negotiating sexual relationships and access to affordable confidential SRH services.
This protocol has been developed to meet a need for guidance on counseling of children and their parents/guardians about HIV/AIDS in 30 USAID/FHI projects with orphans and vulnerable children (OVC) under the IMPACT project in India.
According to the National AIDS Control Organisation (NACO) India has 5.2 million HIV-positive people and an HIV-prevalence of 0.9 percent of adults - about the same as the global average, or the sero-prevalence in North America, Eastern Europe and Central Asia.